| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.003 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |